| Company Name: |
Creative Enzymes |
| Tel: |
1-516-855-7709 |
| Email: |
info@creative-enzymes.com |
|
| | B-NAD SYNTHETASE Basic information |
| Product Name: | B-NAD SYNTHETASE | | Synonyms: | B-NAD SYNTHETASE;Deamido-NAD+:L-glutamine amido-ligase (AMP-forming);β-NAD Synthetase from Escherichia coli;Native Bacillus stearothermophilius NAD Synthetase | | CAS: | 9032-69-3 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![B-NAD SYNTHETASE Structure]() |
| | B-NAD SYNTHETASE Chemical Properties |
| storage temp. | −20°C | | form | lyophilized powder |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-36 | | WGK Germany | 3 |
| | B-NAD SYNTHETASE Usage And Synthesis |
| Uses | NAD synthetase is responsible for the final step in the synthesis of nicotinamide adenine dinucleotide (NAD). The Km values for NAD, ATP, and ammonia of NAD synthetase from Escherichia coli are 200 μM, 11 μM, and 0.65 μM, respectively, while the Km values for NAD, ATP, and ammonia of NAD synthetase from yeast are 170 μM, 190 μM, and 64 μM, respectively. NAD synthetase can be used for enzymatic assays to determine ATP, ammonia, urea, or creatinine, and is also suitable for enzymatic cycling methods. Additionally, NAD synthetase holds potential for research into metabolic diseases, cancer, aging, and neurodegenerative diseases[1][2]. | | References | [1] Zalkin H. NAD synthetase. Methods Enzymol. 1985;113:297-302. DOI:10.1016/s0076-6879(85)13042-9
[2] Xie N, et al. NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduct Target Ther. 2020 Oct 7;5(1):227. DOI:10.1038/s41392-020-00311-7 |
| | B-NAD SYNTHETASE Preparation Products And Raw materials |
|